ECNP School of Neuropsychopharmacology
Call for Applications
Participants at the SCNP 2011 meeting in Oslo are eligible to apply for the third course of the ECNP School of Neuropsychopharmacology. This course will be held from 3-8 July 2011 in Oxford, United Kingdom. SCNP will nominate 2-3 delegates that will attend the course free of charge and have their travel and accommodation expenses subsidized.
Deadline for application is April 1st 2011.
Who can apply?
The candidates would be qualified psychiatrists within 5 years of receiving their defining qualification and are likely to become key leaders of the speciality in the individual countries.
Guidelines to applicants
Applications should be submitted by e-mail to the scientific secretariat: ecnp_school(at)scnp.dk
The application form can be found here.
The Congress venue is situated in the centre of Oslo, only 100 meters from the Central Station and the Express train from Oslo Lufthavn Gadermoen. The Airport shuttle bus stops in front of the hotel. It is close to Oslo's finest shopping, sightseeing and entertainment. The congress venue also has indoor parking facilities if you arrive by car.
10.00- REGISTRATION OPENS
10.00-12.00 SCNP CLINICAL SCALE WORKSHOP
Per Bech (Copenhagen) & Ulrik F. Malt (Oslo)
12.00-13.00 LUNCH
13.00-13.30 General Assembly SCNP
13.45-14.00 PLENARY SESSION
President´s welcome
Ole A. Andreassen (Oslo)
14.00-16.00 PLENARY SESSION
Mood disorders and substance abuse. Cause or consequence?
Moderators: Anne-Liis von Knorring (Uppsala) & Markus Heilig (Washington, DC)
Mood disorders and substance abuse in young people. Psychopathology and epidemiology.
Anne-Liis von Knorring (Uppsala)
Substance abuse: Underlying psychiatric diagnoses
Henrik Rindom (Copenhagen).
Alcohol abuse, depression, and personality; Predictors for violence.
Kent Nilsson (Uppsala-Västerås)
Reward mechanisms common for psychophatology and abuse?
Markus Heilig (Washington, DC)
16.00-16.30 COFFEE BREAK
16.30-18.00 PARALLEL SESSIONS
I. Adult ADHD. An update
Moderators: Jesper Ekelund (Helsinki)
Adult psychopatology and diagnostics
Sami Leppämäki (Helsinki)
ADHD ? progress in treatment
Ylva Ginsberg (Stockholm)
ADHD in adults ? genetic and clinical
Jan Haavik (Bergen)
II. The nitric oxide pathway in psychiatric disease: avenues and perspectives
Moderators: Gregers Wegener (Aarhus) & Caroline Wass (Gothenburg)
Targeting cognitive dysfunctions in schizophrenia: focus on the nitric oxide pathway in rodent models
Erik Pålson (Gothenburg)
The nitric oxide pathway in anxiety and stress-related disorders
Gregers Wegener (Aarhus)
NOS1 as a candidate gene for disorders sharing the feature of impulsivity
Andreas Reif (Würzburg)
Adjunctive L-lysine treatment in patients with schizophrenia
Caroline Wass (Gothenburg)
19.00-21.00 WELCOME RECEPTION
HOSTED BY THE CITY OF GÖTEBORG
BÖRSEN, GUSTAV ADOLFS TORG.